Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Beard

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
JAMA|September 9, 2000
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancerA V D'Amico, D Schultz, M Loffredo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patientsD Kirn, P Mauch, K Shaffer, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Neutrophil defect associated with malignant infantile osteopetrosisC J Beard, L Key, P E Newburger, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapyH K Kim, J M Jessup, C J Beard, et al.
JAMA|September 28, 1998
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort studyJ A Talcott, P Rieker, J A Clark, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancerP L Nguyen, N E Martin, V Choeurng, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
JAMA|September 9, 2000
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancerA V D'Amico, D Schultz, M Loffredo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patientsD Kirn, P Mauch, K Shaffer, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Neutrophil defect associated with malignant infantile osteopetrosisC J Beard, L Key, P E Newburger, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapyH K Kim, J M Jessup, C J Beard, et al.
JAMA|September 28, 1998
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapyA V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort studyJ A Talcott, P Rieker, J A Clark, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancerP L Nguyen, N E Martin, V Choeurng, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.
Pageof 3